Ghana will in the next few weeks start the construction of a facility to produce Covid-19 vaccines under what government calls, Fill and Finish agreement with some global pharmaceutical giants.

The Facility which is a collaboration between Ghana, Senegal, Rwanda and Germany Biotechnology Company will result in the local vaccine for the treatment of viruses as well as tuberculosis and malaria.

President Akufo-Addo disclosed this at the opening of the New Year School at the University of Ghana (UG).

“I am happy to announce that Ghana is on her way to establishing domestic manufacturing plants for the fill, finish and packaging of Covid-19 vaccines.

“I will on 16th February together with His Excellency, Monsieur Macky Sall, President of the Republic of Senegal and His Excellency Mr Paul Kagame, President of the Republic of Rwanda inspect in Mühlberg Germany the production facilities that we need to employ to this end.

“And then to build a pan African project with these two sister African states where initially the fill and finish plant will be located in Ghana,” Akufo-Addo said.

Also, the chairman of the presidential Covid-19 coordinating team Dr. Asamoah Baah explained what the fill and finish process entails.

According to him, “the fill and finish vaccines are already known vaccines like AstraZeneca, Pfizer.”

He added that "the testing has been done, the research has been done, the vaccine is in use and we want to be able to copy it in Ghana. In order to do that you will need government intervention to facilitate discussion between the original owners so that the private sectors would be allowed to copy.”

Meanwhile, Presidential adviser on health Dr. Anthony Nsiah Asare is leading a government delegation currently in Mühlberg, Germany to finalize the deal.